Never mistake a woman’s meekness for weakness,” Serena Joy says in The Handmaid’s Tale. Gilead is a scary place. There is ...

An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...

Gilead Sciences, Inc. (GILD), headquartered in Foster City, California, is a biopharmaceutical company that discovers, ...

Washington has long failed to come up with a solution for rising drug prices that addresses the concerns of drugmakers, ...

Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...

Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Gilead Sciences, Inc. has announced that it has received new approval from the U.S. Food and Drug Administration (FDA) for a ...

Shares of Gilead Sciences Inc. GILD slid 2.15% to $112.29 Thursday, on what proved to be an all-around rough trading session ...

Gilead (GILD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

A 0.35 mile hike and bike trail expansion along Mount Gilead Road is scheduled to begin in August, according to a July 31 ...

Gilead, then a small biotech firm, bought the rights to sell it and, in 1997, worked with doctors from UC San Francisco to show it fought HIV by blocking an enzyme the virus needs to multiply.